Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma 142Leukemia 111Leukemia, Myeloid, Acute 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Lymphoma, Non-Hodgkin 91Multiple Myeloma 88Lymphoma, Large B-Cell, Diffuse 80Myelodysplastic Syndromes 74Lymphoma, Follicular 73Lymphoma, Mantle-Cell 72Leukemia, Lymphocytic, Chronic, B-Cell 69Burkitt Lymphoma 67Hodgkin Disease 66Lymphoma, Large-Cell, Immunoblastic 60Lymphoma, B-Cell, Marginal Zone 49Breast Neoplasms 48Neoplasms, Plasma Cell 39Leukemia, Myeloid, Accelerated Phase 34Leukemia, Myeloid, Chronic-Phase 33Recurrence 32Myeloproliferative Disorders 32Ovarian Neoplasms 31Congenital Abnormalities 30Blast Crisis 30Sarcoma 28Dendritic Cell Sarcoma, Interdigitating 28Central Nervous System Neoplasms 28Leukemia, Myelomonocytic, Chronic 27Neuroblastoma 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 21

Interventions

Sunitinib 4Cyclophosphamide 4Capecitabine 4Bevacizumab 4pazopanib 3Topotecan 3Paclitaxel 3Docetaxel 3Carboplatin 3temsirolimus 2liposomal doxorubicin 2fludarabine 2Sorafenib 2Panobinostat 2NVP-BKM120 2Lapatinib 2Irinotecan 2Immune Checkpoint Inhibitors 2Gemcitabine 2Everolimus 2Erlotinib Hydrochloride 2Doxorubicin 2Bortezomib 2vadimezan 1spartalizumab 1somatostatin receptor 2 1selinexor 1selicrelumab 1perifosine 1pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Solid Tumors × Filgrastim × Clear all
NCT06926751 2026-05-07

Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
132 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡